BioSpace News Archive

Dr. Christian Hassig, CSO, scheduled to present at 10:00 a.m. ET on March 13, 2019

DrFirst enables partners to convert to new standards and stay compliant with ever-expanding rules and regulations

The 2019 SCIEX Microscale Separations, Innovations Medal and Award will be Presented to Dr. Aaron R. Wheeler at MSB 2019

Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has been granted de novo classification by the U.S. Food and Drug Administration (FDA) for the Early Bird Bleed Monitoring System.

Bristol-Myers Squibb Company will take part in a fireside chat at the Cowen and Company 39th Annual Health Care Conference on Tuesday, March 12, 2019, in Boston.

Acceleron Pharma Inc. announced that the United States Food and Drug Administration has granted Orphan Drug designation to ACE-083, the Company’s locally-acting “Myostatin+” muscle agent, for the treatment of patients with Charcot-Marie-Tooth disease.

Acerus Pharmaceuticals Corporation reported its financial results for the three and twelve-month period ended December 31, 2018.

Rocket Pharmaceuticals, Inc., a leading U.S.-based multi-platform gene therapy company, announces participation at the following upcoming industry conferences.

ReForm Biologics, a privately-held pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced a collaboration with Astellas Pharma Inc.

Company’s ioveraº System Offers Targeted, Long-Lasting Non-Opioid Pain Management